Stiehl T
Front Immunol. 2024; 15:1321336.
PMID: 39737169
PMC: 11682905.
DOI: 10.3389/fimmu.2024.1321336.
Zhu C, Stiehl T
Sci Rep. 2024; 14(1):25060.
PMID: 39443599
PMC: 11500015.
DOI: 10.1038/s41598-024-75429-7.
Komarova N, Rignot C, Fleischman A, Wodarz D
Proc Natl Acad Sci U S A. 2024; 121(38):e2321525121.
PMID: 39250660
PMC: 11420203.
DOI: 10.1073/pnas.2321525121.
Boklund T, Snyder J, Gudmand-Hoeyer J, Larsen M, Knudsen T, Eickhardt-Dalboge C
Front Immunol. 2024; 15:1384509.
PMID: 38846951
PMC: 11154009.
DOI: 10.3389/fimmu.2024.1384509.
Zhang D, Cui X, Li Y, Wang R, Wang H, Dai Y
Cell Death Dis. 2023; 14(5):308.
PMID: 37149693
PMC: 10164149.
DOI: 10.1038/s41419-023-05822-z.
Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy.
Rodriguez J, Iniguez A, Jena N, Tata P, Liu Z, Lander A
Elife. 2023; 12.
PMID: 37115622
PMC: 10212564.
DOI: 10.7554/eLife.84149.
HSC Niche Dynamics in Regeneration, Pre-malignancy, and Cancer: Insights From Mathematical Modeling.
Pedersen R, Andersen M, Skov V, Kjaer L, Hasselbalch H, Ottesen J
Stem Cells. 2022; 41(3):260-270.
PMID: 36371719
PMC: 10020982.
DOI: 10.1093/stmcls/sxac079.
An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia.
Przedborski M, Sharon D, Cathelin S, Chan S, Kohandel M
PLoS Comput Biol. 2022; 18(9):e1010439.
PMID: 36099249
PMC: 9469948.
DOI: 10.1371/journal.pcbi.1010439.
Predicting Time to Relapse in Acute Myeloid Leukemia through Stochastic Modeling of Minimal Residual Disease Based on Clonality Data.
Dinh K, Jaksik R, Corey S, Kimmel M
Comput Syst Oncol. 2021; 1(3).
PMID: 34541576
PMC: 8447492.
DOI: 10.1002/cso2.1026.
Computational Reconstruction of Clonal Hierarchies From Bulk Sequencing Data of Acute Myeloid Leukemia Samples.
Stiehl T, Marciniak-Czochra A
Front Physiol. 2021; 12:596194.
PMID: 34497529
PMC: 8419336.
DOI: 10.3389/fphys.2021.596194.
Effective Drug Concentration and Selectivity Depends on Fraction of Primitive Cells.
Lica J, Wieczor M, Grabe G, Heldt M, Jancz M, Misiak M
Int J Mol Sci. 2021; 22(9).
PMID: 34066491
PMC: 8125035.
DOI: 10.3390/ijms22094931.
Understanding the influence of substrate when growing tumorspheres.
Benitez L, Barberis L, Vellon L, Condat C
BMC Cancer. 2021; 21(1):276.
PMID: 33722191
PMC: 7962376.
DOI: 10.1186/s12885-021-07918-1.
Differential response to cytotoxic therapy explains treatment dynamics of acute myeloid leukaemia patients: insights from a mathematical modelling approach.
Hoffmann H, Thiede C, Glauche I, Bornhaeuser M, Roeder I
J R Soc Interface. 2020; 17(170):20200091.
PMID: 32900301
PMC: 7536048.
DOI: 10.1098/rsif.2020.0091.
Mathematical Modeling of MPNs Offers Understanding and Decision Support for Personalized Treatment.
Ottesen J, Pedersen R, Dam M, Knudsen T, Skov V, Kjaer L
Cancers (Basel). 2020; 12(8).
PMID: 32751766
PMC: 7466162.
DOI: 10.3390/cancers12082119.
Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy.
Cortes J, Heidel F, Fiedler W, Smith B, Robak T, Montesinos P
J Hematol Oncol. 2020; 13(1):92.
PMID: 32664995
PMC: 7362563.
DOI: 10.1186/s13045-020-00929-8.
Mathematical modeling reveals the factors involved in the phenomena of cancer stem cells stabilization.
Bessonov N, Pinna G, Minarsky A, Harel-Bellan A, Morozova N
PLoS One. 2019; 14(11):e0224787.
PMID: 31710617
PMC: 6844488.
DOI: 10.1371/journal.pone.0224787.
Oscillations in a white blood cell production model with multiple differentiation stages.
Knauer F, Stiehl T, Marciniak-Czochra A
J Math Biol. 2019; 80(3):575-600.
PMID: 31559452
DOI: 10.1007/s00285-019-01432-6.
A structured population model of clonal selection in acute leukemias with multiple maturation stages.
Lorenzi T, Marciniak-Czochra A, Stiehl T
J Math Biol. 2019; 79(5):1587-1621.
PMID: 31350582
DOI: 10.1007/s00285-019-01404-w.
Clonal hematopoiesis of indeterminate potential and its impact on patient trajectories after stem cell transplantation.
Park D, Akuffo A, Muench D, Grimes H, Epling-Burnette P, Maini P
PLoS Comput Biol. 2019; 15(4):e1006913.
PMID: 31026273
PMC: 6505959.
DOI: 10.1371/journal.pcbi.1006913.
In-silico comparison of two induction regimens (7 + 3 vs 7 + 3 plus additional bone marrow evaluation) in acute myeloid leukemia treatment.
Banck J, Gorlich D
BMC Syst Biol. 2019; 13(1):18.
PMID: 30704476
PMC: 6357450.
DOI: 10.1186/s12918-019-0684-0.